Brain metastases in HER2-positive breast cancer

被引：8
|
作者：
Lin, Nancy U. [1 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Div Womens Canc, Boston, MA 02215 USA
来源：
LANCET ONCOLOGY | 2013年 / 14卷 / 03期
关键词：
NERVOUS-SYSTEM METASTASES; TRASTUZUMAB; LAPATINIB; WOMEN;
D O I：
10.1016/S1470-2045(13)70046-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：185 / 186
页数：3
相关论文
共 50 条
  • [31] Evaluating Strategies to Deliver HER2-Targeted Radioimmunoconjugates to the Brain for the Treatment of HER2-Positive Breast Cancer Brain Metastases
    Kondo, Misaki
    Chan, Conrad
    Cai, Zhongli
    Reilly, Raymond
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [32] HER2-positive breast cancer
    Loibl, Sibylle
    Gianni, Luca
    LANCET, 2017, 389 (10087): : 2415 - 2429
  • [33] Tucatinib in the Treatment of HER2-positive Breast Cancer High Activity even in Patients with Brain Metastases
    Banys-Paluchowski, Maggie
    Krawczyk, Natalia
    ONKOLOGE, 2020, 26 (10): : 966 - 969
  • [34] Efficacy and Safety of Radiotherapy Combined with Pyrotinib in the Treatment of HER2-Positive Breast Cancer with Brain Metastases
    Huang, Jie
    Zhu, Wenqiang
    Duan, Qiangzhi
    Zhu, Chaomang
    Shi, Xueling
    Zhao, Hongyu
    Cai, Peng
    Li, Duojie
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 841 - 853
  • [35] Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival
    Y S Yap
    G H Cornelio
    B C R Devi
    C Khorprasert
    S B Kim
    T Y Kim
    S C Lee
    Y H Park
    J H Sohn
    N Sutandyo
    D W Y Wong
    M Kobayashi
    S H Landis
    E M Yeoh
    H Moon
    J Ro
    British Journal of Cancer, 2012, 107 : 1075 - 1082
  • [36] Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer
    Chien, A. Jo
    Rugo, Hope S.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 1 - 12
  • [37] Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions
    Azim, Hamdy A.
    Azim, Hatem A., Jr.
    FUTURE ONCOLOGY, 2012, 8 (02) : 135 - 144
  • [38] CLINICAL EFFICACY OF PYROTINIB COMBINING WITH STEREOTACTIC RADIOSURGERY IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES
    Zhen, Juanjie
    Bashir, Shoaib
    Yang, Yanying
    Wang, Hui
    Lai, Mingyao
    Cai, Linbo
    NEURO-ONCOLOGY, 2024, 26
  • [39] Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival
    Yap, Y. S.
    Cornelio, G. H.
    Devi, B. C. R.
    Khorprasert, C.
    Kim, S. B.
    Kim, T. Y.
    Lee, S. C.
    Park, Y. H.
    Sohn, J. H.
    Sutandyo, N.
    Wong, D. W. Y.
    Kobayashi, M.
    Landis, S. H.
    Yeoh, E. M.
    Moon, H.
    Ro, J.
    BRITISH JOURNAL OF CANCER, 2012, 107 (07) : 1075 - 1082
  • [40] RESPONSE TO T-DM1 IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES (BM)
    Berghoff, A. S.
    Bartsch, R.
    Bergen, E.
    Rudas, M.
    Gnant, M.
    Dieckmann, K.
    Pinker, K.
    Zielinski, C. C.
    Steger, G. G.
    Preusser, M.
    NEURO-ONCOLOGY, 2014, 16
12345